<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: The aim of the study was to determine the relative frequency of orofacial malignant <z:hpo ids='HP_0002664'>neoplasm</z:hpo> in children and adolescents </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: A retrospective review of malignant orofacial <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> in children and adolescents &lt;or=19 years from January 1992 to December 2003 from the records of the Department of Oral Pathology and Biology of the Lagos University Teaching Hospital, Nigeria was carried out </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> the cases were analysed for age, gender, site distribution and histologic types </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: A total of 353 tumours and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-like lesions of the orofacial region were seen in patients &lt;or=19 years during the period of the study </plain></SENT>
<SENT sid="4" pm="."><plain>Of these, 47 (13.3%) were <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignant tumours</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>This represented 3.3% (47 out of 1431) of <z:hpo ids='HP_0000001'>all</z:hpo> the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-like lesions seen during the period </plain></SENT>
<SENT sid="6" pm="."><plain>The mean age (S.D.) of patients was 11.0 (+/-4.5) years (range, 2.5-19 years) </plain></SENT>
<SENT sid="7" pm="."><plain>Male-to-female ratio was 2.9:1 </plain></SENT>
<SENT sid="8" pm="."><plain>Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (38.3%) was the most frequent <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignant tumours</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0002665'>Lymphomas</z:hpo> (53.2%) were the most common <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e>, followed by <z:hpo ids='HP_0100242'>sarcomas</z:hpo> (36.2%) and <z:mp ids='MP_0002038'>carcinomas</z:mp> (10.6%) </plain></SENT>
<SENT sid="10" pm="."><plain><z:mp ids='MP_0002038'>Carcinomas</z:mp> exclusively affected patients in the 2nd decade of life and were predominantly <z:mp ids='MP_0009308'>glandular carcinomas</z:mp> </plain></SENT>
<SENT sid="11" pm="."><plain><z:hpo ids='HP_0002669'>Osteosarcoma</z:hpo> and <z:hpo ids='HP_0002859'>rhabdomyosarcoma</z:hpo> were the most common <z:hpo ids='HP_0100242'>sarcomas</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (72%) occurring mostly in the first decade of life was the most common <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSIONS: Malignant <z:hpo ids='HP_0002664'>neoplasm</z:hpo> constituted 13.3% of orofacial <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-like lesions in children and adolescent in our centre </plain></SENT>
<SENT sid="14" pm="."><plain>In agreement with previous reports from Africa, Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> is the most common <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignant tumour</z:e> and <z:mp ids='MP_0002038'>carcinoma</z:mp> is relative rare in this age group </plain></SENT>
</text></document>